Dennis Slamon

BMRN

Dennis Slamon serves as Director at BioMarin Pharmaceutical Inc. (BMRN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$1.30M

Net Position

Net Seller

$1.30M

Companies Traded

BMRN

Active Period

Feb 2022 – Mar 2024

2 total trades

Most Recent

Sell BMRN

Mar 18, 2024 · $797.0K

Dennis Slamon's Insider Trading at BioMarin Pharmaceutical Inc. (BMRN)

Buys

0 · $0.00

Sells

2 · $1.30M

Total Shares Bought

Total Shares Sold

15,906

BMRN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 18, 2024↗	Sell	9,510	$83.81	$797.0K	0
Feb 28, 2022↗	Sell	6,396	$78.33	$501.0K	0

Related Insiders

Charles Greg Guyer

officer: EVP, Chief Technical Officer

BMRNSell · Mar 11, 2026

Gregory R Friberg

officer: EVP, Chief R&D Officer

BMRNSell · Feb 26, 2026

George Eric Davis

officer: EVP, Chief Legal Officer

BMRNSell · Feb 26, 2026

Alexander Hardy

Chief Executive Officer

BMRNSell · Dec 1, 2025

Gregory R Friberg

EVP, Chief R&D Officer

BMRNSell · Sep 30, 2025

Erin Burkhart

GVP, Chief Accounting Officer

BMRNSell · May 20, 2025

Cristin Hubbard

EVP, Chief Commercial Officer

BMRNSell · May 20, 2025

Brian Mueller

EVP, Chief Financial Officer

BMRNSell · Mar 14, 2025

Explore More Insider Trading Data

BMRN Insider Trading Activity

View all insider trades at BioMarin Pharmaceutical Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity